Global Patent Litigation Strategies -- Navigating the Complex Web of International IP Disputes

A modern smartphone, electric vehicle, wireless earbud, or networked thermostat is a global product. It is designed in one country, assembled from components sourced in a dozen others, and sold simultaneously in markets on every continent. When that product is accused of infringing a patent, the dispute does not respect the borders the product crossed so effortlessly. The same underlying technology may be protected by a family of related patents in the United States, across Europe, in China, in Japan, and in Korea — and the patent owner can, if it chooses, sue in all of them at once.

This article is a practical, in-depth guide to litigating patents across borders. It is written so that a judge, a seasoned intellectual-property litigator, and an interested business owner with no legal training can all follow it. Every term of art is explained in plain language the first time it appears, and the discussion is grounded throughout in concrete examples — many of them hypothetical, with clearly labeled invented parties such as "Acme Corp." and "Beacon Devices, Ltd."

We move from foundations to tactics. First, the single most important concept in international patent law: territoriality. Then the treaty machinery — the Paris Convention, the Patent Cooperation Treaty, and the European Patent Convention — that lets an inventor convert one invention into an enforceable portfolio in scores of countries. From there we tour the principal battlegrounds: the U.S. district courts and the International Trade Commission; the new Unified Patent Court and the national courts of Europe, with special attention to Germany's bifurcated system, the United Kingdom, and the surging role of China; and the major Asian venues of Japan and Korea. We then take up the defining legal war of the past decade — the fight over standard-essential patents (SEPs) and "FRAND" licensing — including the Huawei v. ZTE protocol, global rate-setting, and the escalation of anti-suit and anti-anti-suit injunctions. Finally, we cover the connective tissue that makes a global campaign work or fail: cross-border discovery, the coordination of parallel proceedings, settlement architecture, and the enforcement of judgments across borders.

If you are litigating a single U.S. patent dispute end to end, you may find our comprehensive guide to patent infringement litigation from summary judgment denial to post-trial a useful companion. For the deep mechanics of SEPs in next-generation networks, see standard-essential patents and FRAND licensing in 5G and IoT. And for vivid illustrations of how these doctrines actually play out, global patent wars: lessons from high-profile case studies gathers the marquee disputes in one place. Readers new to the underlying right may also want the plain-language grounding in patent basics and what constitutes patent infringement before diving in.

Part One: The Bedrock Principle of Territoriality

What "territoriality" means and why everything flows from it

A patent is a creature of the nation that grants it. A United States patent gives its owner the right, under 35 U.S.C. § 271, to exclude others from making, using, selling, offering to sell, or importing the patented invention within the United States (and, in limited circumstances, from supplying components from the United States for assembly abroad). It confers no rights whatsoever in Germany, China, or Japan. Conversely, a German patent is enforceable in Germany and nowhere else. There is no such thing as a "world patent."

This is the principle of territoriality: patent rights are independent, country by country, and each is governed exclusively by the law of the granting state. The U.S. Supreme Court has repeatedly emphasized the point — most memorably in Microsoft Corp. v. AT&T Corp., 550 U.S. 437 (2007), reaffirming "the general rule under United States patent law that no infringement occurs when a patented product is made and sold in another country." The Court returned to territoriality in WesternGeco LLC v. ION Geophysical Corp., 138 S. Ct. 2129 (2018), allowing recovery of foreign lost profits, but only because the relevant statutory conduct — supplying components from the United States under § 271(f) — occurred domestically.

Three practical consequences follow from territoriality, and they shape every cross-border strategy.

First, a patent owner who wants protection in a market must obtain a patent in that market. An invention disclosed publicly with no patent filing in China is free for anyone to practice in China. This is why portfolio building (Part Two) is inseparable from litigation strategy.

Second, infringement, validity, and remedies are decided separately in each country, under that country's law. The same patent family can be held valid in one country and invalid in another; infringed in one and not in another; enjoined in one while damages-only in another. A German court applying the European Patent Convention's inventive-step standard and a U.S. court applying the Graham v. John Deere obviousness framework can — and regularly do — reach opposite conclusions on essentially the same prior art. For a granular tour of how that obviousness analysis runs in the United States, see our guide to overcoming obviousness rejections under Section 103.

Third, a national court generally cannot adjudicate the validity of a foreign patent. In the European Union, this rule was crystallized in Gesellschaft für Antriebstechnik mbH (GAT) v. Lamellen und Kupplungsbau Beteiligungs KG (LuK), Case C-4/03 (ECJ 2006), which held that proceedings concerning the validity of a patent fall within the exclusive jurisdiction of the courts of the state of registration — and that this exclusivity is triggered however validity is raised, whether by claim, counterclaim, or merely as a subsidiary defense. The companion decision in Roche Nederland BV v. Primus, Case C-539/03 (ECJ 2006), handed down the same day, then held that infringements of parallel national designations of a European patent by different defendants are not "irreconcilable" claims that can be consolidated in a single court, effectively killing the Dutch "spider-in-the-web" theory of cross-border consolidation. Together these decisions explain why, for nearly two decades, enforcing a European patent meant a separate lawsuit in each country — and why the Unified Patent Court, discussed in Part Four, was such a watershed.

A worked example to anchor the discussion

Throughout this article we will return to a running hypothetical. Acme Corp., a U.S.-headquartered chip designer, holds a family of patents on a power-management circuit used in wireless devices. Beacon Devices, Ltd., a manufacturer incorporated in Asia, sells a line of earbuds and smart speakers globally that Acme believes use the circuit. Acme has parallel patents in the United States, before the European Patent Office, in China, Japan, and Korea. Beacon manufactures in China, imports finished goods into the United States and the EU, and sells worldwide. Some of Acme's patents are simply proprietary improvements; others Acme declared "essential" to a wireless audio standard and committed to license on fair, reasonable, and non-discriminatory terms. As we move through each forum, we will ask: where should Acme sue, what can it win, and how should Beacon defend? (To be clear, Acme and Beacon are entirely fictional; the example is a teaching device, not a description of any real company or case.)

Part Two: Building a Coordinated Multinational Portfolio

Litigation strategy begins years before any complaint is filed, at the prosecution stage, because you can only sue on patents you actually obtained in the relevant country. The international treaty system gives inventors a structured, deadline-driven path from a single first filing to a worldwide portfolio. Understanding that path is essential both to building enforceable rights and to attacking an adversary's rights.

Paris Convention priority: the twelve-month head start

The Paris Convention for the Protection of Industrial Property (1883, as revised) is the foundational treaty, with more than 175 member states. Its central mechanism for patents is the right of priority under Article 4. When an applicant files a first patent application in one member country, it has twelve months to file corresponding applications in other member countries and claim the original filing date as the priority date for all of them.

Why does this matter so much? Because patentability is judged against the prior art — the body of public knowledge — as it existed on the priority date. The twelve-month window means an inventor's own later public disclosures, sales, or competitors' filings during that year cannot be used against the later-filed foreign applications. In our hypothetical, if Acme filed first in the United States on 1 March 2024, it can file in Germany, China, Japan, and Korea any time before 1 March 2025 and still be judged as of the March 2024 date. Miss the deadline by a day, and the intervening year of public activity becomes citable prior art — frequently fatal.

A recurring litigation theme is the priority attack: an accused infringer argues that the patent-in-suit is not actually entitled to its claimed priority date — for example, because the earliest application did not adequately describe the later-claimed invention — thereby opening the door to a year's worth of additional invalidating prior art. Because priority requirements are evaluated under each country's law and the precise "same invention" standard varies (the EPC frames it through Articles 87–88 and a strict identity-of-disclosure test, while U.S. law looks to written-description and enablement support under 35 U.S.C. § 112), a priority claim can survive in one forum and collapse in another. This is one reason the careful drafting work described in our guide to preparing an invention disclosure for your patent attorney pays dividends years later.

The Patent Cooperation Treaty: one application, many destinations

The Patent Cooperation Treaty (PCT), administered by the World Intellectual Property Organization (WIPO), is the workhorse of international filing. With over 150 contracting states, the PCT lets an applicant file a single "international application" that has the legal effect of a national filing in every member country. The applicant receives an international search report and a preliminary, non-binding opinion on patentability, then has until roughly 30 or 31 months from the priority date to enter the "national phase" — that is, to commit to (and pay for) prosecution in each individual country or region it has selected.

The PCT does not grant a "PCT patent." It is a procedural deferral mechanism: it buys time and information before the expensive, irrevocable decisions about where to seek protection. For a company like Acme, the PCT route preserves optionality. Acme can file a PCT application within twelve months of its U.S. filing (often as the very vehicle for claiming Paris priority), watch how Beacon's product line and the relevant markets develop for another year and a half, and only then decide whether the China and Korea filings are worth the cost.

The European Patent Convention and the unitary patent

The European Patent Convention (EPC) created the European Patent Office (EPO), which conducts a single centralized examination and grants a European patent. The EPO is not an EU institution; its membership extends beyond the EU to states such as Switzerland, Norway, Turkey, and the United Kingdom. Critically, until recently a granted European patent was not a single unitary right; it was a bundle of national patents, one for each EPC member state in which the patentee chose to "validate" it. Each national designation then lived or died in its own country's courts. (This is why, historically, a single Apple–Samsung European dispute could spawn separate German, UK, Dutch, and French actions on what was nominally "the same" European patent.)

There is one important centralized attack on a European patent at the EPO itself: the opposition. Under Article 99 EPC, for nine months after grant any third party can file an opposition, and a successful opposition revokes the patent in all designated states at once — the single most efficient way to clear a European patent off the board. The trade-off is speed: an opposition that runs through appeal to the Technical Boards of Appeal can easily exceed four years. The asymmetries are notable too — a patent revoked at the EPO cannot be reinstated nationally, but a patent upheld at the EPO can still be revoked by a national court. Miss that nine-month window, and (outside the new Unified Patent Court system) a challenger must attack each national designation separately, country by country.

Even where substantive law is nominally harmonized across EPC states, national courts are not strictly bound by EPO jurisprudence. The UK Supreme Court explained in Human Genome Sciences Inc. v. Eli Lilly & Co., [2011] UKSC 51, that national courts should "normally follow the established jurisprudence" of the EPO's Boards of Appeal but may decline to do so on unusual facts — deferring to settled EPO principles of law while reserving independent judgment on the application of law to the facts.

Since June 2023, the EPC framework has been overlaid with the unitary patent and the Unified Patent Court (UPC), discussed at length in Part Four. A patentee can now elect, upon grant, to obtain a single unitary patent covering the participating EU states as one indivisible right, enforceable and revocable in a single UPC proceeding. This is a structural change of the first magnitude, and it has reshaped the calculus for both portfolio building and enforcement in Europe.

Choosing where to file, with litigation in mind

Because every national filing costs money — translation, local agents, official fees, and annual renewal fees that escalate over the patent's life — no company patents everywhere. The portfolio decision is a litigation decision in disguise. A sophisticated patentee asks: Where is the product made? Where is it sold in volume? Where are injunctions readily available and fast? Where are damages large? Where is the defendant's manufacturing or design center, such that an injunction would hurt most?

For an inventor preparing to build such a portfolio, the upstream work matters enormously; our guides on how to license your patent: from valuation to term sheet and conducting freedom-to-operate analysis for new products address adjacent foundations. And because validity will be contested in every forum, the prosecution-stage strategies in responding to patent office actions: strategies for overcoming rejections directly affect how robust the litigation portfolio will be — every concession made to an examiner becomes a potential weapon in an infringer's hands.

Part Three: Forum Selection in the United States

The United States offers two fundamentally different patent-enforcement systems running in parallel: the federal district courts and the U.S. International Trade Commission. They have different remedies, different speeds, different decision-makers, and different strategic uses. A global campaign almost always involves a deliberate choice between them — and often a coordinated use of both. Federal courts have exclusive subject-matter jurisdiction over patent claims (Gunn v. Minton, 568 U.S. 251 (2013)), and all patent appeals route to a single specialized appellate court, the Court of Appeals for the Federal Circuit (28 U.S.C. § 1295(a)(1)) — a centralization that gives U.S. patent law a degree of national uniformity many other countries lack.

District court litigation: damages, juries, and the venue revolution

A patent owner can sue for infringement in federal district court under 35 U.S.C. § 271, seeking damages (a reasonable royalty at minimum under § 284, lost profits where provable), and in appropriate cases a permanent injunction under § 283. The United States is unusual among major jurisdictions in several respects that drive global forum choices.

First, the right to a jury trial. In a district court patent case, either party may demand a jury (the demand is due within fourteen days after the last pleading directed to the issue, Fed. R. Civ. P. 38(b)), and juries decide infringement, validity, willfulness, and damages. The judge, by contrast, construes the claims — the "single most important event" in many cases — in a Markman hearing, because claim construction is a question of law for the court (Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996); Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 574 U.S. 318 (2015)), and the judge decides equitable issues such as permanent injunctions and inequitable conduct (there is no jury right for injunction-only cases, Paice LLC v. Toyota Motor Corp., 504 F.3d 1293 (Fed. Cir. 2007)). Juries are capable of very large verdicts, and this is a major reason damages awards in the United States dwarf those almost everywhere else, and a major reason patent owners gravitate to U.S. district courts when money is the goal.

Second, enhanced damages and fee shifting are the exception, not the rule. Under § 284, a court may award up to treble damages for willful infringement, the standard for which the Supreme Court relaxed in Halo Electronics, Inc. v. Pulse Electronics, Inc., 579 U.S. 93 (2016). Under § 285, a court may award attorneys' fees in "exceptional" cases — those that "stand out" from others in the substantive strength of a party's position or the unreasonable manner of litigation (Octane Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545 (2014)). But the American baseline is that each side bears its own fees — a sharp contrast to the "loser pays" regimes prevailing in Europe and much of Asia, and a factor that makes U.S. litigation attractive to plaintiffs with weaker cases.

The third structural feature — injunctions — changed dramatically with eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006). Before eBay, a patentee who proved infringement of a valid patent was nearly guaranteed a permanent injunction. eBay abolished that presumption and required the traditional four-factor equitable test: (1) irreparable injury; (2) inadequacy of money damages; (3) the balance of hardships; and (4) the public interest. The practical effect has been that non-practicing entities — patent owners who do not make products and therefore can usually be made whole with money — rarely obtain injunctions, and SEP holders who promised to license almost never do. This single decision is a primary driver of the move to foreign forums and to the ITC, where injunctive-style relief remains available.

Venue is the other defining feature of U.S. district-court strategy. For decades, patent plaintiffs flocked to the Eastern District of Texas, a "rocket docket" perceived as plaintiff-friendly. The Supreme Court curtailed that practice in TC Heartland LLC v. Kraft Foods Group Brands LLC, 581 U.S. 258 (2017), holding that under the patent venue statute, 28 U.S.C. § 1400(b), a domestic corporation "resides" only in its state of incorporation. The Federal Circuit's In re Cray Inc., 871 F.3d 1355 (Fed. Cir. 2017), then tightened the alternative basis — a "regular and established place of business" must be a physical place — and In re Google LLC, 949 F.3d 1338 (Fed. Cir. 2020), confirmed the point. The result reshuffled the deck: the District of Delaware (where many companies are incorporated) and the Western District of Texas (home to a single, very active patent judge for several years) became dominant. Note one crucial wrinkle for cross-border cases: foreign defendants may be sued for patent infringement in any district, because the venue statute's restrictions do not protect non-U.S. corporations (Brunette Machine Works, Ltd. v. Kockum Industries, Inc., 406 U.S. 706 (1972)). In our hypothetical, Beacon — an Asian corporation — enjoys none of TC Heartland's venue protection in the United States, which materially expands Acme's options.

Speed varies enormously by district, and the differences are strategically meaningful. According to Federal Court Management Statistics and litigation-analytics data, the Eastern District of Texas reaches trial in roughly 19 months on average, the Western District of Texas (Waco) in about 26 months, the Northern District of California in roughly 37 months, and the District of Delaware in nearly 38 months. A plaintiff seeking fast leverage and a defendant hoping to slow a case to a crawl are, in effect, fighting over which of these clocks will govern.

The International Trade Commission and Section 337

The U.S. International Trade Commission (ITC) is a federal agency, not a court, but for patent owners it is one of the most powerful weapons in the world. Under Section 337 of the Tariff Act of 1930, 19 U.S.C. § 1337, the ITC investigates "unfair acts" in the importation of articles into the United States, which expressly includes importation of articles that infringe a valid U.S. patent. Because virtually all consumer electronics are imported, Section 337 reaches almost the entire technology industry. Investigations are conducted under the Commission's Rules of Practice and Procedure (19 C.F.R. Part 210), with an administrative law judge issuing an initial determination subject to Commission review and appeal to the Federal Circuit.

Three features make the ITC distinctive and, for many patentees, irresistible.

Speed. ITC investigations move on a statutory fast track. The Commission must decide whether to institute within roughly 30 days of a complaint and then issues a Notice of Investigation. An ALJ typically holds an evidentiary hearing within roughly nine to ten months of institution and issues an initial determination, with a final Commission determination usually within about 16 to 18 months. A 60-day Presidential Review Period follows any remedial order, during which the President (in practice, the U.S. Trade Representative) may disapprove the order for policy reasons. For a patentee seeking leverage, this tempo is far faster than most district courts.

The exclusion order. The ITC cannot award damages. Its remedies are an exclusion order, directing U.S. Customs and Border Protection to bar infringing imports at the border, and a cease-and-desist order against domestic inventory and sales. An exclusion order functions as a de facto injunction — and, importantly, the ITC is not bound by eBay. The Federal Circuit confirmed in Spansion, Inc. v. ITC, 629 F.3d 1331 (Fed. Cir. 2010), that the eBay four-factor test does not govern ITC exclusionary relief; instead the Commission weighs statutory public-interest factors. This makes the ITC the premier forum for a patentee who wants exclusionary relief that eBay would deny in district court. Violation of a cease-and-desist order, moreover, exposes the respondent to civil penalties of up to $100,000 per day or twice the value of the goods, whichever is greater (19 U.S.C. § 1337(f)) — teeth that concentrate the mind.

The domestic industry requirement. The price of admission is that the complainant must prove a "domestic industry" in the United States relating to articles protected by the asserted patent — investment in plant, equipment, labor, or capital (the "economic prong"), or substantial investment in engineering, research and development, or licensing. This is the ITC's gatekeeping feature and a frequent battleground; a foreign patentee with no U.S. footprint may struggle to establish it, whereas a licensing-based domestic industry has been accepted where the licensing relates to the asserted patent.

Two further doctrines matter for cross-border practice. The ITC's authority over induced infringement where the direct infringement occurs only after importation was confirmed in Suprema, Inc. v. ITC, 796 F.3d 1338 (Fed. Cir. 2015) (en banc). There, the asserted method claim could not be infringed at the moment of importation — the imported scanners infringed only once combined with software and used domestically — yet the en banc court held that the phrase "articles that infringe" in § 1337 does not track the § 271 definitions of infringement, and that the ITC could reach goods that, after importation, are used by the importer to directly infringe at the seller's inducement. The court reasoned that any narrower reading would be "an open invitation to foreign entities ... to circumvent Section 337 by importing articles in a state requiring post-importation combination." Suprema significantly expanded the agency's reach over imported components later assembled into infringing systems. And because the ITC and district courts can run simultaneously on the same patents, a common pattern is to file both: the ITC for fast exclusionary pressure, the district court (often stayed under 28 U.S.C. § 1659 pending the ITC investigation) preserved for damages.

For Acme, the ITC is a natural opening move against Beacon's imported earbuds. A successful Section 337 investigation could bar those products at the U.S. border within roughly a year and a half — a commercial catastrophe for Beacon that creates enormous settlement pressure, entirely independent of any damages Acme might later collect. Acme's challenge will be the domestic-industry prong; if it makes or licenses the patented circuit in the United States, it qualifies, but if Acme is a pure foreign rights-holder, Beacon will attack that threshold hard.

PTAB validity challenges as a parallel front

Whenever a U.S. patent is asserted, the accused infringer can counterattack at the Patent Trial and Appeal Board (PTAB) through inter partes review (IPR), a streamlined administrative proceeding to cancel claims as anticipated or obvious over patents and printed publications. IPRs are fast (a final written decision is statutorily due within 12 months of institution, extendable to 18) and have a meaningful invalidation rate, though a petitioner who loses faces estoppel under 35 U.S.C. § 315(e) on grounds it raised or reasonably could have raised. For a global defendant like Beacon, an IPR is an efficient way to knock out the U.S. members of Acme's patent family, and a PTAB win can ripple outward as persuasive (though not binding) evidence in foreign validity proceedings on parallel patents.

Part Four: Europe — The Unified Patent Court and the National Systems

Europe has been transformed. For decades, enforcing a European patent meant litigating country by country, in parallel, with all the cost and inconsistency that implies. As an earlier era's commentators put it, European patent enforcement was a "Gordian knot": a single granted European patent dissolved on grant into a bundle of national rights, GAT v. LuK fragmented validity to the country of registration, Roche v. Primus foreclosed cross-border consolidation of infringement claims, and an earlier attempt at a unified court was held incompatible with EU law in Opinion 1/09 of the Court of Justice (8 March 2011). Since 1 June 2023, the Unified Patent Court has cut that knot, offering for the first time a single court that can grant — or revoke — patent rights across most of the European Union in one proceeding. Yet the national systems remain vital, both as alternatives and as the only route for patents that opt out of the new regime.

The Unified Patent Court: pan-European relief in a single action

The UPC is a court common to the participating EU member states (the large markets — Germany, France, Italy, the Netherlands, and others — are in; notably, the United Kingdom is not, having withdrawn after Brexit, and Spain has stayed out). It has jurisdiction over both unitary patents and, unless they have been opted out, the traditional European patents validated in participating states.

The UPC's defining feature is the scope of its judgments. A single UPC infringement action can yield an injunction and damages spanning all participating states at once; a single revocation action can invalidate the patent across all of them. This is a double-edged sword: it offers patentees unprecedented efficiency and leverage (one win, continental injunction), but it concentrates risk for patentees too (one loss, continental revocation). That centralized-risk dynamic is precisely why the UPC system includes an opt-out: during a transitional period, holders of traditional European patents may opt out of the UPC's jurisdiction, keeping those patents in the national-courts-only world and shielding them from a single knockout blow. Whether to opt out — patent by patent — has become one of the most consequential portfolio decisions a European patentee makes.

Structurally, the UPC has a Court of First Instance with local and regional divisions hosted in member states, plus a central division (seated in Paris, with sections in Munich and Milan) that handles, among other things, standalone revocation actions. A Court of Appeal sits in Luxembourg, providing pan-European consistency that the old national-by-national system could never deliver. Early practice has shown the UPC to be fast, willing to grant preliminary injunctions on a robust showing, and capable of substantial damages — making it, very quickly, a top-tier global forum. For Acme, a UPC action could deliver a continent-wide injunction against Beacon's EU sales in a single proceeding; for Beacon, a UPC central-division revocation action offers the chance to clear the European patent in one stroke.

Germany: bifurcation and the "injunction gap"

Even with the UPC live, Germany remains the most important national patent-litigation venue in Europe, and its system has long exerted outsized influence on global strategy because of one structural feature: bifurcation.

In Germany, infringement and validity are decided by different courts in separate proceedings. Specialized regional courts (notably Düsseldorf, Mannheim, and Munich) hear infringement. They do not, however, rule on whether the patent is valid. A defendant who wants to challenge validity must bring a separate nullity action in the Federal Patent Court in Munich (or rely on an EPO opposition). Crucially, the infringement court generally will not wait for the validity decision unless it considers the patent highly likely to be invalidated.

The consequence is the famous "injunction gap." German infringement courts are fast and grant injunctions essentially automatically upon a finding of infringement — there is no eBay-style discretionary balancing in the classic German model (though a 2021 statutory reform introduced a narrow proportionality consideration in exceptional cases). Because the nullity proceeding takes considerably longer, a patentee can win an injunction and enforce it before the validity question is ever resolved — even if the patent is later revoked. This gives patentees in Germany extraordinary leverage. A defendant facing a German injunction on a product it sells across Europe may be forced to settle globally long before it can prove the patent was invalid all along.

This dynamic explains why so many global campaigns have a German spearhead. In our hypothetical, Acme might file infringement in Mannheim while Beacon races to invalidate in the Federal Patent Court and the EPO; if Acme wins infringement first, the injunction gap hands it enormous settlement leverage regardless of the ultimate validity outcome. Defendants counter with strong, fast-tracked nullity attacks and, where possible, EPO oppositions aimed at killing the whole bundle at once.

The United Kingdom: thorough, candid, and globally influential

The United Kingdom, outside both the EU and the UPC, occupies a distinctive niche. UK patent litigation (in the Patents Court of the High Court, and the lighter-weight Intellectual Property Enterprise Court for smaller disputes) hears infringement and validity together in a single, rigorous trial, typically concluding within about a year. The UK has no juries for patent cases; technically expert judges decide. It permits genuine document disclosure and cross-examination of expert witnesses, producing trials that are thorough and well-reasoned — and, under the English "loser pays" costs rule, expensive for the losing side.

UK courts are known for a willingness to find patents invalid and for candid, technically detailed judgments that are widely cited abroad. But the UK's outsized global influence in the past decade comes from one area in particular: its courts' assertion of jurisdiction to set global FRAND licensing rates for standard-essential patents — the subject of Part Six. A negative UK validity finding, or a UK global-rate determination, can reshape a worldwide dispute even though the UK is a comparatively small market.

China: from emerging venue to global heavyweight

Perhaps the single most important shift in global patent litigation is the rise of China. Once dismissed by Western rights-holders, China now hears more patent cases annually than any other country, has built a sophisticated specialized judiciary, and has positioned itself as a venue capable of influencing disputes worldwide.

China established dedicated IP courts in Beijing, Shanghai, and Guangzhou, plus numerous specialized IP tribunals, and in 2019 created an IP appeals tribunal within the Supreme People's Court to unify technical-patent appeals nationally — a centralizing reform that has improved consistency. Chinese courts are fast by international standards, injunctions are routinely available upon a finding of infringement, and damages — historically modest — have risen substantially, aided by an amended Patent Law (effective June 2021) introducing enhanced punitive damages of up to five times actual damages for willful infringement and raising statutory damage caps.

Two features make China strategically pivotal in global campaigns. First, as both the world's largest manufacturing base and an enormous consumer market, China is where many products are made — so a Chinese injunction can choke off supply at the source. Second, Chinese courts have signaled willingness to set global FRAND rates (notably in the Sharp v. OPPO line, where the Supreme People's Court upheld jurisdiction over a global rate by reference to connecting factors such as the place of implementation and the locus of negotiations) and, as discussed in Part Six, have aggressively deployed anti-suit injunctions to protect their jurisdiction over SEP disputes, making China not merely a battlefield but sometimes the decisive one. For both Acme and Beacon — who manufacture in China — Chinese proceedings carry weight far beyond the local market. Litigants should also note that serving and gathering evidence in China is uniquely demanding; see our practitioner's guides linked in Part Seven.

Japan and Korea: disciplined, predictable, increasingly assertive

Japan offers a mature, judge-driven system concentrated in specialized IP divisions of the Tokyo and Osaka District Courts, with appeals to the IP High Court. First-instance decisions typically arrive in a little over a year. Validity can be challenged both through a Japan Patent Office invalidation trial and, since the Kilby line of cases and subsequent statutory amendment, as an invalidity defense in the infringement court itself. Japan is known for procedural rigor and predictability; historically patentee win rates and damages have been comparatively modest, though recent reforms (including enhanced damages provisions and improved evidence-gathering procedures) have strengthened the patentee's hand. The JPO's 2018 Guide to Licensing Negotiations Involving Standard Essential Patents also made Japan an early mover in articulating FRAND expectations.

Korea, anchored by the specialized Patent Court in Daejeon and IP divisions of the district courts, has likewise become a meaningful venue — fast, technically capable, and home to some of the world's largest technology manufacturers, which makes it a natural forum when a Korean company is on either side of a dispute. Korea, too, has adopted enhanced damages for willful infringement and improved discovery-like mechanisms, signaling a broader Asian trend toward stronger patent enforcement.

Part Five: Procedural and Substantive Differences That Drive Strategy

A global litigator must internalize that the "same" patent dispute looks profoundly different from one forum to the next. The differences are not cosmetic; they dictate where to file and what to expect.

Decision-maker, speed, and the bifurcation question

Only the United States routinely puts patent questions to a jury; nearly everywhere else, technically trained judges decide. This affects everything from how a case is framed to how damages are argued. Speed varies widely: the ITC and Germany's infringement courts are among the fastest, the UK delivers comprehensive single trials in about a year, and U.S. district courts range from sub-two-year "rocket dockets" to multi-year campaigns. And the structure of the proceeding — whether infringement and validity are tried together (United States, United Kingdom, the UPC in most postures) or split apart (Germany's bifurcation) — can be the single most outcome-determinative feature, because it creates or eliminates the injunction gap that hands patentees leverage.

The following table distills the forum landscape into a single view. It is a generalization — every case turns on its facts — but it captures the trade-offs a global strategist weighs.

Substantive law: prior art, claim construction, and patent types

While the move to first-inventor-to-file under the America Invents Act (for applications filed on or after 16 March 2013) brought the United States closer to the rest of the world, important substantive divergences persist. The legal test for whether an invention is patentable differs: U.S. law asks about novelty (§ 102) and non-obviousness (§ 103), while the EPC frames the inquiry as novelty (Article 54) and inventive step (Article 56), assessed through the EPO's structured "problem-and-solution" approach. These are not mere labels; they can produce different outcomes on identical prior art, and prominent UK judges have openly criticized the EPO's problem-and-solution method for inviting hindsight.

Claim construction — how a court determines what the patent's claims actually cover — also differs. U.S. courts give claims their ordinary meaning to a person of ordinary skill in the art in light of the specification and prosecution history (Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc)). German and UK courts use a more purposive construction centered on the inventive concept (the UK drawing on Kirin-Amgen Inc. v. Hoechst Marion Roussel Ltd. and successor cases), and the UPC is developing its own harmonized approach. The doctrine of equivalents, too, varies in scope — German courts have historically read it more generously than UK courts. The same claim can therefore be read more broadly in one forum than another.

Finally, the types of rights available diverge. Utility models — fast, often unexamined, shorter-term patent-like rights — exist in Germany, China, Japan, Korea, and elsewhere, but not in the United States or United Kingdom. They can be powerful tactical tools: a patentee can branch a utility model off a pending application and assert it quickly, while the same invention's full patent is still in examination. Software and business-method eligibility likewise varies; the U.S. Alice/Mayo framework (discussed in our companion article on patent eligibility after Alice) has no exact analogue abroad, and the EPC's exclusion of computer programs "as such" under Article 52 generates its own distinct case law. And the question of AI-generated inventions and machine inventorship is being answered differently across jurisdictions — a reminder that even fundamental questions of who can be an inventor are not globally settled.

Available remedies, compared

The remedy menu is the practical heart of forum selection. The United States offers large jury damages, possible treble damages for willfulness, ITC exclusion orders — but, post-eBay, difficult district-court injunctions. Germany and the UPC offer fast, robust injunctions (the UPC continent-wide), with damages typically more modest than U.S. levels. The United Kingdom offers injunctions, full validity adjudication, "loser pays" costs, and uniquely, global FRAND rate-setting. China offers fast injunctions, rising damages including punitive multipliers, and supply-chain leverage. The art of global strategy is matching the client's objective — money, market exclusion, a forced design-around, or a global license — to the forum whose remedies best deliver it.

Part Six: The SEP and FRAND Wars

No area better illustrates the strategic complexity of global patent litigation than disputes over standard-essential patents (SEPs). These have generated the most aggressive cross-border maneuvering of the modern era, including the extraordinary phenomenon of courts on different continents enjoining each other's proceedings.

What SEPs and FRAND commitments are

When industries agree on technical standards — so that a phone made by one company can connect to a network built by another, or earbuds from one maker can pair with a speaker from another — those standards are developed by standard-setting organizations (SSOs) such as ETSI (telecommunications) and the IEEE. Standards inevitably incorporate patented technology. A patent that must be infringed to comply with a standard is a standard-essential patent. The numbers are staggering: more than 200,000 patents have been declared essential to ETSI standards alone, although studies suggest only a fraction — by some estimates around 20% — of declared SEPs actually read on the standard, making essentiality itself a fiercely contested question.

Essentiality creates power. Once a technology is locked into a standard that the whole industry has adopted, the patent owner can hold up every implementer: comply with the standard (and infringe) or be shut out of the market. This is patent holdup — the risk that an SEP owner will charge royalties far exceeding the patent's true technological contribution by exploiting the leverage the standard conferred. To counter it, SSOs require members to commit, in advance, to license their declared-essential patents on fair, reasonable, and non-discriminatory (FRAND) terms (called RAND in the U.S. context). The SEP owner gets paid; the implementer gets access; the royalty is supposed to reflect the patent's value, not the standard's coercive power.

The mirror-image problem is holdout (or "reverse holdup"): an implementer that drags out negotiations and infringes for years, betting that the worst case is paying a FRAND royalty it would have owed anyway. The entire FRAND legal architecture is an attempt to balance these two abuses, and reasonable enforcers disagree about which is the greater danger — the U.S. Department of Justice under one administration treated holdup as essentially a contract problem rather than an antitrust harm, while the European Commission has taken a more interventionist stance.

For the technical and licensing mechanics of SEPs in modern networks, see our detailed companion piece, standard-essential patents and FRAND licensing in 5G and IoT.

FRAND, injunctions, and the Huawei v. ZTE framework

Because a FRAND commitment is, in effect, a promise to accept money, courts have been reluctant to let SEP owners obtain injunctions — the ultimate "comply or exit" threat. In the United States, eBay already makes SEP injunctions in district court nearly unattainable, and courts have treated the FRAND promise as a strong signal that damages are adequate. In Europe, the Court of Justice of the EU established a structured protocol in Huawei Technologies Co. v. ZTE Corp., Case C-170/13 (CJEU 2015): before seeking an injunction on a FRAND-committed SEP, the patentee must (1) notify the implementer of the infringement, identifying the patent and the manner of infringement; (2) after the implementer expresses willingness to license, make a specific written FRAND offer with the royalty and its calculation; and (3) the implementer must respond diligently and, if it disagrees, make a FRAND counteroffer and, if that is rejected, provide security and render an account. An SEP owner who follows the protocol against an unwilling implementer can obtain an injunction; one who skips the steps risks an abuse-of-dominance defense under Article 102 TFEU.

German courts have built a demanding body of law around this framework. The Federal Court of Justice (Bundesgerichtshof) in the Sisvel v. Haier decisions (KZR 36/17, 5 May 2020, and KZR 35/17, 24 November 2020) held that an implementer must clearly and unambiguously declare its willingness to take a license on FRAND terms and then cooperate purposefully and react diligently throughout — and that delay can itself mark the implementer as "unwilling." Lower German courts have treated a five-month delay in responding to an infringement notice as too long (Saint Lawrence v. Vodafone). The practical upshot is that the willing/unwilling-licensee distinction has become the central battleground in European SEP litigation, and the UPC now applies the same Huawei v. ZTE analysis.

Global rate-setting: Unwired Planet, InterDigital, and the UK's bold move

The deepest tension in SEP litigation is between territoriality and the global nature of a license. An implementer like Beacon sells one product worldwide; it wants a single worldwide license, not a patchwork of country-by-country deals. But a court only has jurisdiction over its own patents. Can a national court set a global FRAND rate?

The UK Supreme Court answered yes in Unwired Planet International Ltd. v. Huawei Technologies Co., [2020] UKSC 37 (affirming [2017] EWHC 711 (Pat) and [2018] EWCA Civ 2344). Reasoning that ETSI's FRAND undertaking is, in substance, a contract contemplating worldwide licensing — and that commercial parties in the real world license globally — the Court held that English courts can determine a global FRAND rate and condition relief on the implementer's acceptance of it. In practice this means an English court can tell an implementer: take this worldwide license at this rate, or face an injunction barring your products from the UK market. Even though the UK is a modest market, the threat of UK exclusion can compel acceptance of a global rate. The UK confirmed and extended this approach in subsequent InterDigital v. Lenovo litigation, where the Patents Court conducted a full global FRAND rate-setting trial and determined a worldwide royalty — cementing the UK as a forum where a single judgment can resolve a global SEP license.

This was a watershed. It meant that whoever wins the race to judgment in a jurisdiction willing to set global rates can effectively dictate the worldwide outcome. Other courts noticed. Chinese courts have asserted comparable authority to set global SEP rates (the Sharp v. OPPO line), and U.S. courts have grappled with the issue too. The first U.S. RAND-rate determination came in Microsoft Corp. v. Motorola, Inc., No. C10-1823-JLR, 2013 WL 2111217 (W.D. Wash. Apr. 25, 2013), where Judge Robart adapted the fifteen Georgia-Pacific reasonable-royalty factors (Georgia-Pacific Corp. v. U.S. Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970)) into a RAND analysis that accounted for royalty stacking and valued the technology itself rather than its inclusion in the standard — arriving at a few cents per unit against Motorola's demand of roughly $4.50 on a $199 console. Later cases such as TCL Communication Technology Holdings, Ltd. v. Telefonaktiebolaget LM Ericsson, 943 F.3d 1360 (Fed. Cir. 2019), and HTC Corp. v. Telefonaktiebolaget LM Ericsson, 12 F.4th 476 (5th Cir. 2021), wrestled with rate methodologies and the appropriate royalty base. The upshot: multiple courts now claim power to set the global rate, and they can reach different numbers — setting the stage for direct jurisdictional conflict.

A worked SEP example

Return to Acme and Beacon, and assume the dispute centers on Acme's declared-essential audio-streaming patents. Beacon wants one worldwide license; Acme wants the highest defensible rate. Acme sends a Huawei v. ZTE-compliant notice identifying the patents and supplying claim charts, then makes a written FRAND offer with a transparent royalty calculation. Beacon, sensing that Acme will run to the UK to have an English judge set a global rate, files first in China seeking a lower global rate and simultaneously asks the Chinese court for an anti-suit injunction to stop Acme from pursuing the UK case. Acme races to the UK Patents Court and to a German infringement court, asking the German court for a pre-emptive anti-anti-suit injunction. Whoever wins this procedural footrace — and whether Beacon is later branded an "unwilling" licensee for its delay — may determine the worldwide royalty more decisively than the technical merits of any single patent. This is the recurring pattern of real SEP wars, simply relabeled with fictional parties.

Anti-suit and anti-anti-suit injunctions: courts at war

When two courts on different continents each claim authority to set the global rate, a party can try to stop its opponent from pursuing the other court. The tool is the anti-suit injunction (ASI) — an order directing a party (not the foreign court itself) not to prosecute, or to enforce a judgment in, the proceedings before another court. The target court's natural response is the anti-anti-suit injunction (AASI) — an order forbidding the party from obtaining or enforcing the first court's anti-suit injunction. Some disputes have escalated to anti-anti-anti-suit injunctions, a spiraling jurisdictional arms race.

U.S. courts assess anti-suit injunctions through a doctrine that long predates the SEP wars, and the federal circuits are split. The "permissive" approach (followed in the Fifth, Seventh, and Ninth Circuits) grants an injunction where the foreign litigation is vexatious or oppressive and accords comity less weight; the Ninth Circuit applied it in Microsoft Corp. v. Motorola, Inc., 696 F.3d 872 (9th Cir. 2012), to bar enforcement of a German SEP injunction. The "restrictive" approach (Third, Sixth, Eighth, and D.C. Circuits) gives heavy weight to international comity and grants relief only where the foreign action threatens the enjoining court's jurisdiction or an important public policy — the framework of the leading case Laker Airways Ltd. v. Sabena, Belgian World Airlines, 731 F.2d 909 (D.C. Cir. 1984), which also recognized the legitimacy of a counter (anti-anti-suit) injunction to protect validly invoked jurisdiction. The intermediate First and Second Circuit approach (e.g., China Trade & Development Corp. v. M.V. Choong Yong, 837 F.2d 33 (2d Cir. 1987)) weighs the totality of circumstances against a presumption disfavoring the injunction. Across every approach, the order runs against the party, so the court must first have personal jurisdiction over it.

The cross-border collision crystallized in the early 2020s. Chinese courts issued ASIs barring SEP owners from pursuing or enforcing foreign injunctions while Chinese global-rate proceedings were pending (notably in Huawei v. Conversant and Xiaomi v. InterDigital), with steep daily penalties for violation. In response, courts in Germany, the United States, and elsewhere began issuing AASIs to protect their own proceedings — U.S. examples include Ericsson Inc. v. Samsung Electronics Co. (E.D. Tex. 2021) — and Germany's courts in particular grew willing to grant pre-emptive AASIs to forestall a foreign ASI before it could issue. The conflict became so pronounced that the European Union filed a case against China at the World Trade Organization, alleging that China's ASI practice unlawfully restricted EU rights-holders' ability to enforce their patents.

For a global litigator, the lesson is stark: in a contested SEP dispute, the sequence and venue of filings can be decisive, because the first court to assert global-rate jurisdiction may try to enjoin all the others — and the response will determine whether the patentee or the implementer controls the forum in which the worldwide rate is set.

Competition-law overlay

SEP disputes also implicate antitrust and competition law, and here too jurisdictions diverge. In the United States, the trend has been to channel FRAND disputes into contract and patent law rather than antitrust; the Ninth Circuit's reversal in FTC v. Qualcomm Inc., 969 F.3d 974 (9th Cir. 2020), held that Qualcomm's "no license, no chips" licensing practices, even if aggressive, did not violate the Sherman Act, reflecting judicial reluctance to treat FRAND breaches as antitrust violations. Earlier FTC enforcement had taken the opposite tack, extracting consent orders barring SEP injunctions against willing licensees (for example, the 2013 In re Motorola Mobility/Google consent agreement). The European Union, by contrast, treats seeking an injunction outside the Huawei v. ZTE protocol as a potential abuse of dominance under Article 102 TFEU. The EU has also moved toward regulating SEPs directly, proposing a framework for SEP transparency and FRAND rate determination administered through the EU Intellectual Property Office — a sign that, increasingly, SEP licensing is being shaped not only by litigation but by regulation. Practitioners assessing antitrust exposure should also consult our discussion of standard-essential patents and FRAND licensing in 5G and IoT, which addresses the licensing-level (component vs. end-product) debates that animate these antitrust theories.

Part Seven: Cross-Border Discovery and Service

A global dispute requires global evidence — documents, source code, sales data, and witnesses scattered across jurisdictions with sharply different rules about what may be obtained and how. Discovery is one of the largest practical divides in international litigation: the United States permits broad, party-driven discovery; most of the rest of the world permits far less, and some countries actively prohibit the kind of wide-ranging disclosure American litigators take for granted.

28 U.S.C. § 1782: the powerful U.S. tool for foreign cases

A remarkable feature of U.S. law is 28 U.S.C. § 1782, which allows a U.S. federal court to order a person "found" in the district to give testimony or produce documents "for use in a proceeding in a foreign or international tribunal." In plain terms: a party to a German or Chinese patent case can come to a U.S. court and obtain discovery — under generous U.S. standards — from a person or company located in the United States, for use abroad. The Supreme Court construed § 1782 broadly in Intel Corp. v. Advanced Micro Devices, Inc., 542 U.S. 241 (2004), which set out the discretionary factors courts weigh: whether the target is a party to the foreign proceeding (non-parties are more likely subject to § 1782 because they may be beyond the foreign court's reach), the nature of the foreign tribunal and its receptivity to U.S. assistance, whether the request circumvents foreign proof-gathering restrictions, and whether it is unduly burdensome. The Court later limited § 1782's reach in ZF Automotive US, Inc. v. Luxshare, Ltd., 596 U.S. 619 (2022), holding that "foreign or international tribunal" covers governmental and intergovernmental adjudicative bodies but not private commercial arbitration panels — a meaningful constraint for parties hoping to use § 1782 to feed a private arbitration.

For a global patent campaign, § 1782 is a strategic asset: a litigant fighting Acme in Munich might use § 1782 in the Northern District of California to extract documents from a U.S.-based supplier or licensee that German procedure could never reach. Conversely, a U.S.-based party should anticipate that its foreign adversaries may use § 1782 against it at home.

The Hague Evidence Convention, Aérospatiale, and foreign blocking statutes

When evidence sits abroad, the formal channel is the Hague Convention on the Taking of Evidence Abroad in Civil or Commercial Matters (the Hague Evidence Convention). It allows a court in one signatory state to issue a letter of request (a "letter rogatory") to a designated Central Authority in another, asking that authority to compel the evidence under local procedure. The process is reliable but slow and narrow; the letter must be specific (broad, U.S.-style document demands are routinely cut down or refused), and many civil-law countries entered reservations under Article 23 declining to execute requests for U.S.-style pre-trial document production, so the Convention often yields far less than American discovery would.

Crucially, the Hague Evidence Convention is not the exclusive route to evidence abroad. The Supreme Court held in Société Nationale Industrielle Aérospatiale v. U.S. District Court for the Southern District of Iowa, 482 U.S. 522 (1987), that a U.S. court may order a party already subject to its jurisdiction to produce foreign evidence directly under the Federal Rules, subject to a comity analysis. The Aérospatiale factors — (1) the importance of the information to the litigation, (2) the specificity of the request, (3) whether the information originated in the United States, (4) the availability of alternative means, and (5) the extent to which non-compliance would undermine the interests of the foreign state — guide that analysis. In practice, most U.S. courts applying these factors find that American discovery interests outweigh foreign privacy interests and order direct production (see, e.g., Knight Capital Partners Corp. v. Henkel AG & Co., 290 F. Supp. 3d 681 (E.D. Mich. 2017)).

That comity analysis is where foreign blocking statutes and data-protection laws collide with U.S. discovery. France's blocking statute, China's data-security and personal-information laws, and the EU's General Data Protection Regulation (GDPR) can all make it unlawful, under the foreign country's law, to transfer the very documents a U.S. court orders produced — and the GDPR's penalties run to the greater of EUR 20 million or 4% of global annual revenue. The result is a genuine bind: comply with the U.S. order and risk foreign penalties, or honor foreign law and risk U.S. sanctions. Sophisticated parties manage the conflict with protective orders, anonymization, in-place review within the EU, standard contractual clauses, and reliance on the GDPR's Article 49 derogation for transfers "necessary for the establishment, exercise or defense of legal claims." Navigating cross-border data transfer is a discipline of its own — see our analysis of international data transfers after Schrems II. Practitioners must plan evidence strategy early, mapping where critical documents live and which legal regime governs their movement.

Serving the foreign defendant

Before any of this, the patentee must lawfully serve the foreign defendant — itself a frequent stumbling block. Service abroad is governed by the Hague Convention on the Service Abroad of Judicial and Extrajudicial Documents, which the Supreme Court has held is mandatory and preemptive where it applies (Volkswagenwerk Aktiengesellschaft v. Schlunk, 486 U.S. 694 (1988)). The primary method is transmission through the destination state's Central Authority, which typically serves and returns proof within roughly two to six months; service by mail is permitted only where the destination state has not objected (Water Splash, Inc. v. Menon, 137 S. Ct. 1504 (2017)) and the forum's own rules independently authorize it. Importantly, Fed. R. Civ. P. 4(m)'s 90-day service deadline does not apply to service abroad, and a court may authorize alternative service under Rule 4(f)(3) if a Central Authority fails to respond within six months. China, Germany, Japan, and others have objected to mail and direct-agent service, so the Central Authority route is often the only safe path.

Service on Chinese defendants, in particular, is notoriously slow and procedurally exacting; our practitioner's guide on serving defendants in China: methods and strategy under the Hague Service Convention addresses the pitfalls in detail, and our related piece on serving legal documents to Chinese defendants in IP litigation offers additional strategy. In our hypothetical, properly serving Beacon's Chinese manufacturing entity may take many months — a timing reality Acme must build into its multi-forum sequencing.

Part Eight: Coordinating Parallel Proceedings and Engineering a Global Settlement

A global campaign is not a collection of independent lawsuits; it is one integrated strategy executed through many local teams. Coordination is the difference between a coherent worldwide pincer and a series of contradictory, self-defeating filings.

Consistency across borders — and its limits

The cardinal coordination risk is inconsistent positions. A patentee that argues for a broad claim construction in Mannheim to capture Beacon's product, but a narrow construction in a PTAB proceeding to dodge prior art, invites the accused infringer to wave the German brief in front of the U.S. tribunal. Statements made to the EPO can be used in U.S. courts; admissions in a U.S. deposition can surface in a Chinese proceeding. A central strategy team must therefore vet key technical and claim-construction positions for global consistency before any local team commits to them — and must remember that U.S. discovery, including the § 1782 device, can expose a party's foreign filings to its adversary.

At the same time, perfect uniformity is neither possible nor desirable, precisely because the law differs. A patent may be valid under Chinese law and invalid under the EPC; an argument that wins before a German judge may fall flat before a U.S. jury. The art is to maintain consistency on facts and core technical positions while tailoring legal arguments to each forum's doctrine. A loss in one country does not dictate a loss in another — a foreign judgment of invalidity has, at most, persuasive weight elsewhere, never preclusive effect, because each patent is a separate national right.

Sequencing and the race to leverage

Because forums differ in speed and remedy, sequence is a weapon. A common pattern: open with the fastest exclusionary forum (the ITC, a German infringement court, or a Chinese court) to generate near-term pressure, while slower, damages-oriented proceedings (a U.S. district court action) and validity counterattacks (IPRs, EPO oppositions, nullity actions) run in the background. The first injunction often dictates the settlement. The defendant's counter-sequencing mirror-images this: file the fastest, broadest validity attack (an EPO opposition that can kill the whole European bundle, an IPR on the U.S. family), seek to stay the slower infringement cases, and — in SEP cases — race to a global-rate forum or seek an anti-suit injunction to seize control of where the worldwide rate gets set.

Defendants must also weigh the countersuit. A classic response to a patent assertion is to assert one's own patents back against the plaintiff's products in a forum where the plaintiff is exposed — turning a one-front attack into a two-front war and creating the mutual exposure that drives cross-licenses. If Beacon holds patents Acme practices, a Beacon countersuit in Korea or China can transform the entire negotiation.

The global settlement and arbitration

The vast majority of global patent campaigns end not in a final judgment everywhere but in a comprehensive worldwide settlement — typically a global cross-license and a lump-sum or running-royalty payment that resolves all pending and threatened actions in all countries at once. The whole multi-forum apparatus is, in a sense, machinery for establishing the leverage that sets the settlement price. A patentee with a German injunction and a pending ITC exclusion order negotiates from a far stronger position than one with only a slow U.S. damages case.

Because global disputes are so costly and fragmented, parties increasingly turn to international arbitration to resolve the whole tangle in a single neutral forum whose award is enforceable in most of the world under the New York Convention (codified in the United States at 9 U.S.C. §§ 201–208, with a three-year window to confirm an award under § 207). Arbitration is especially attractive for FRAND disputes, where the core question is simply a global rate and where confidentiality and a single decision-maker are valuable. Our broader treatment of arbitration as alternative dispute resolution explains the mechanics; for patent licensing specifically, an arbitration clause in a license can pre-commit the parties to resolve future FRAND or royalty disputes globally and privately. The flip side — recall ZF Automotive — is that choosing private arbitration forfeits the § 1782 discovery tool.

Part Nine: Enforcing Judgments Across Borders

Winning is not the same as collecting. A patentee that obtains a damages judgment in one country and needs to enforce it against assets in another confronts the law of recognition and enforcement of foreign judgments — an area where, unlike service and evidence, there is no comprehensive global treaty in force among the major patent jurisdictions.

The United States has no bilateral judgment-enforcement treaties and no federal statute requiring recognition; the question is governed by state law, and most states have adopted a version of the Uniform Foreign-Country Money Judgments Recognition Act (2005) or its 1962 predecessor. Under the Act, a court will generally enforce a foreign money judgment that is final, conclusive, and enforceable where rendered — but recognition is mandatorily refused if the rendering court lacked impartial tribunals or due process, or lacked personal jurisdiction, and may be discretionarily refused for inadequate notice, fraud, conflict with another judgment, or a result repugnant to public policy. The Act covers only money judgments, so a foreign injunction falls outside it and must be addressed, if at all, through common-law comity (the Hilton v. Guyot, 159 U.S. 113 (1895), framework). A few states (notably Massachusetts and Arizona) add a reciprocity requirement that can defeat enforcement outright, and the Act sets a limitations period of fifteen years (or the foreign country's shorter period) to bring the recognition action. Within the EU, by contrast, judgments circulate relatively freely under the Brussels I Recast Regulation, and UPC judgments are directly enforceable across participating states. The Hague Convention of 2 July 2019 on the Recognition and Enforcement of Foreign Judgments promises a broader multilateral framework as it gathers ratifications, but it remains a work in progress and contains carve-outs relevant to IP.

Two practical points dominate. First, injunctions are territorial in effect, so a patentee usually does not need to "enforce" a foreign injunction abroad — it enforces the injunction where it was granted, against conduct there. The value of a German or Chinese injunction lies in its bite in that market (and in the supply chain it disrupts), not in exporting the order elsewhere. Second, for money judgments, the patentee must locate the defendant's assets and assess, jurisdiction by jurisdiction, whether and how a foreign judgment can be recognized against them. Sophisticated parties consider enforceability before choosing where to litigate damages: a large award is worth little if the defendant's assets sit in a country that will not recognize the judgment. Where an arbitral award rather than a court judgment is in hand, the New York Convention's near-universal enforceability is a decisive advantage — one more reason FRAND and licensing disputes gravitate toward arbitration.

Part Ten: A Strategic Synthesis — Building the Global Campaign

Pulling the threads together, a disciplined global patent strategy proceeds through a recognizable sequence of decisions.

It begins with objectives. Money, market exclusion, a forced design-around, and a global license each point toward different forums. A patentee whose goal is exclusion looks to the ITC, Germany, the UPC, and China; one whose goal is a large damages recovery looks to U.S. juries; one whose goal is a worldwide FRAND license looks to the UK or another global-rate forum.

It proceeds to a portfolio and exposure audit. Which patents are strong and where? Where is the defendant manufacturing, designing, and selling? Where is its supply chain vulnerable? What is the defendant's own patent portfolio, and what countersuit risk does it pose? A candid assessment of validity exposure — informed by prior-art searching that mirrors what each forum will scrutinize — is indispensable, because the fastest way to lose a global campaign is to assert a patent that an EPO opposition or IPR will revoke.

It then sets a forum map and sequence: which cases to file, in what order, to maximize early leverage while preserving slower high-value claims and bracing for the defendant's validity counterattacks and countersuits. In SEP cases, this map must account for the global-rate race and the anti-suit/anti-anti-suit dynamic — deciding whether to be the party that seizes the global-rate forum or to defend against an opponent who does.

It establishes coordination infrastructure: a central strategy team, vetted global positions on the technical and claim-construction questions that recur everywhere, secure cross-border information-sharing that respects privilege differences and data-protection law, and a plan for the cross-border discovery (§ 1782, Hague letters of request) and service (Hague Service Convention) the campaign will need.

And throughout, it keeps the endgame in view. Because almost every global campaign settles, every filing should be understood as an investment in leverage toward a worldwide resolution. The question is never merely "can we win this motion in Düsseldorf?" but "how does winning this motion in Düsseldorf move the global settlement number?"

For the firms and businesses that get this right, the prize is real: the ability to protect and monetize innovation on a worldwide scale, matching the global reach of the products that embody it. For those who get it wrong — inconsistent positions, a revoked anchor patent, an opponent who wins the global-rate race — a multimillion-dollar campaign can collapse on a single foreign ruling.

Frequently Asked Questions

Is there such a thing as a "worldwide patent"? No. Patents are strictly territorial; each country grants and governs its own. The closest things to centralized rights are the EPO's centralized examination (which still yields a bundle of national patents unless you elect a unitary patent) and the new EU unitary patent, which is a single right across participating EU states — but even that does not cover the United States, China, Japan, Korea, the United Kingdom, or most of the world. To enforce a patent in a country, you must have obtained a patent there.

Why do companies sue in so many countries at once instead of just one? Because a single product sold worldwide can be attacked from many directions, and different forums offer different advantages — fast injunctions in Germany and China, exclusion orders at the U.S. ITC, large damages from U.S. juries, and global FRAND rate-setting in the UK. Multi-forum litigation diversifies risk (a loss in one country does not bind the others), multiplies the defendant's exposure and cost, and builds the leverage needed for a favorable worldwide settlement.

What makes the U.S. International Trade Commission so attractive to patent owners? Speed and exclusionary power. A Section 337 investigation typically reaches a final determination in about 16 to 18 months and can result in an exclusion order barring infringing imports at the U.S. border, backed by cease-and-desist penalties of up to $100,000 per day. Crucially, the ITC is not bound by the eBay injunction standard, so it can grant border exclusion even where a district court would deny an injunction — making it the premier U.S. forum for stopping imported products. The trade-off is that the complainant must prove a U.S. "domestic industry," and the ITC cannot award damages.

What is a FRAND commitment, and why does it limit injunctions? When a patent is essential to a technical standard everyone must use, the patent owner usually promised the standard-setting organization to license it on fair, reasonable, and non-discriminatory terms. That promise is, in effect, a commitment to accept money rather than exclude — so courts (under eBay in the U.S. and the Huawei v. ZTE protocol in the EU and UPC) are reluctant to grant injunctions on FRAND-committed patents against a willing licensee, though they may against an unwilling one. German law, through the Sisvel v. Haier line, treats foot-dragging by the implementer as a mark of unwillingness.

Can a court in one country really set a global patent licensing rate? For standard-essential patents, increasingly yes. The UK Supreme Court held in Unwired Planet v. Huawei that English courts can set a worldwide FRAND rate and condition relief on the implementer accepting it; the UK InterDigital v. Lenovo litigation did exactly that. Chinese courts have asserted similar authority in the Sharp v. OPPO line. Because multiple courts now claim this power and can reach different numbers, the result has been a "race to judgment" and the use of anti-suit injunctions to control which court sets the global rate.

How do anti-suit and anti-anti-suit injunctions work? An anti-suit injunction is an order from one court directing a party (not the foreign court) not to pursue or enforce litigation elsewhere. The targeted court may respond with an anti-anti-suit injunction forbidding the party from obtaining or enforcing the first order. U.S. courts apply varying standards depending on the circuit — some weigh comity heavily (the Laker Airways line), others focus on whether the foreign suit is vexatious (Microsoft v. Motorola). In recent SEP disputes, Chinese courts issued anti-suit injunctions to protect their global-rate proceedings, and German and U.S. courts responded with anti-anti-suit injunctions — a jurisdictional arms race that even prompted an EU complaint against China at the WTO.

How do I get discovery or serve a defendant located abroad? For documents in the United States usable in a foreign case, 28 U.S.C. § 1782 lets a U.S. court order production under the Intel factors (but not for private arbitration, per ZF Automotive). For evidence located abroad, the Hague Evidence Convention's letter-of-request procedure is the formal channel, though many countries restrict U.S.-style document discovery; alternatively, a U.S. court may order a party within its jurisdiction to produce foreign documents directly after a comity analysis under Aérospatiale. To serve a foreign defendant, the Hague Service Convention usually governs, most reliably through the destination country's Central Authority — a process that can take several months, especially for Chinese defendants.

If I win a damages judgment abroad, can I collect it in the United States? Possibly, but it is not automatic. The United States has no global judgment-enforcement treaty; recognition is governed by state law (often a version of the Uniform Foreign-Country Money Judgments Recognition Act), and a U.S. court will examine whether the foreign court had proper jurisdiction and provided fair procedures, and whether the judgment offends public policy. A few states also require reciprocity. Injunctions, by contrast, are enforced where they are granted, against local conduct — so the value of a German or Chinese injunction is its effect in that market and supply chain, not its portability.

Key Takeaways

Patents are territorial: there is no world patent, and infringement, validity, and remedies are decided independently in each country under that country's law. Everything in global litigation flows from this single principle. Building enforceable rights worldwide requires disciplined use of the treaty system — Paris Convention priority, the PCT, the EPC, and the new unitary patent — years before any complaint is filed.

Forum selection is the heart of strategy. The U.S. district courts offer juries and large damages but, post-eBay, difficult injunctions; the ITC offers fast exclusion orders unconstrained by eBay (and, after Suprema, reaching even post-importation induced infringement); Germany offers fast injunctions and a bifurcation-driven "injunction gap"; the UPC offers continent-wide relief in a single action; the UK offers thorough trials and global FRAND rate-setting; and China has become a global heavyweight with fast injunctions, rising punitive damages, and decisive supply-chain leverage. Japan and Korea round out a maturing, increasingly assertive Asian landscape.

Standard-essential patents have produced the most aggressive cross-border maneuvering of the era — the Huawei v. ZTE protocol, FRAND injunction limits, global rate-setting in Unwired Planet and InterDigital, and the spiraling anti-suit/anti-anti-suit injunction wars — making the sequence and venue of filings potentially decisive. Cross-border discovery (§ 1782, the Hague Evidence Convention, and the Aérospatiale comity analysis), careful coordination of parallel proceedings, and clear-eyed planning for the recognition and enforcement of judgments are the connective tissue that determines whether a global campaign coheres into worldwide leverage or fractures on a single foreign ruling. And because nearly every global campaign ends in a comprehensive worldwide settlement, every filing should be understood as an investment in the leverage that sets the global deal.

Related Articles

• Comprehensive Guide to Patent Infringement Litigation: From Summary Judgment Denial to Post-Trial
• Standard-Essential Patents and FRAND Licensing in 5G and IoT
• Global Patent Wars: Lessons from High-Profile Case Studies
• What Constitutes Patent Infringement
• Patent Basics: A Plain-English Guide
• Overcoming Obviousness Rejections: A Comprehensive Guide to Section 103 Analysis
• Serving Defendants in China: Methods and Strategy Under the Hague Service Convention
• Patent Eligibility After Alice: Strategies for Protecting Software and Business Method Innovations
• Conducting Freedom-to-Operate Analysis for New Products
• How to License Your Patent: From Valuation to Term Sheet
• Responding to Patent Office Actions: Strategies for Overcoming Rejections
• International Data Transfers After Schrems II
• Arbitration: A Comprehensive Guide to Alternative Dispute Resolution
• Artificial Intelligence and Inventorship: Global Perspectives on Machine Contributions to Innovation

Disclaimer: This article is provided by mclaw.io for general informational purposes only and does not constitute legal advice, nor does it create an attorney-client relationship. International patent litigation involves rapidly evolving law that varies significantly by jurisdiction, and the strategies discussed here must be tailored to specific facts and current law in each relevant country. Readers should consult qualified patent counsel licensed in the appropriate jurisdictions before making any decisions about patent portfolio building, enforcement, or defense.